Toray TRY-003D – Analysis by EarlyGuard™ miRNA from Women Referred for Additional Testing Due to Abnormal Breast Imaging Classified as Bl-RADS® of 3, 4, or 5 (Toray TRY-003D)
This protocol describes a simple, non-significant risk (NSR) clinical study, in which a single 5.0 – 10.0 mL sample of whole blood is drawn from each enrolled Subject meeting requirements of one of the three Study arms.
Principal Investigator(s)
Suzanne Rose, PhD
Sponsor(s)
Toray International America, Inc.
Contact
Hospitalist at 203-358-8879 or [email protected]
Location
Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-276-2695
Stamford, CT 06902
Main: 203-276-2695